Wednesday, 5 August 2026 Stay informed. No noise.

Global Filmmakers Are Leveraging Kling AI to Push the Boundaries of Storytelling, Cannes Panel Presents

CANNES, FRANCE – Media OutReach Newswire – 28 May 2026 – A shift is underway in the global film industry as creators across the globe embrace Kling AI to produce cinematic-level visuals and push the boundaries of storytelling.

Native 4K Generation for Cinematic-Level Output

“For House of David, we did it for a third of what the studios told us we needed,” said Jon Erwin, the writer and producer of House of David, founder and Chief Creative Officer of Wonder Project.

For House of David, Kling AI has served as its core foundation model and benchmark tool. Across both season one and two, Kling AI has generated the vast majority of its production shots, leading the share of its AI workflows for the show. While Season One of House of David incorporated 72 shots invovling the use of AI, its second season used more than four times as many AI shots compared to the first season.

Emotional Expressiveness for Feature Film

Raphael, South Korea’s first full-length feature created entirely using generative AI, is a large-scale production being developed by Mateo AI Studio. Currently in production with the goal of a theatrical release in 2026, this project is leveraging Kling AI’s powerful video model throughout the production process to maximize distinctive visual effects and deliver a differentiated cinematic experience.

Realism and Visual Quality for Theatrical Screens

Born of the Tide, the first AI-generated cinematic epic exploring China’s Tanka community, often referred to as “sea nomads” for their long-standing floating way of life, leverages Kling AI’s 4K capabilities to present its sweeping, high-stakes spectacles, such as massive dragon boat races, explosive fish market bombings, and sprawling mountain battles.

“Kling AI faithfully preserves the director’s intended color tones without losing stylistic consistency during the video generation process. The platform also delivers rare realism in rendering waves, torrential rain, and the intricate, glistening reflections of firelight across wet wooden ship planks—textures that stand out as unmatched among AI models,” said Wei Li, director of Born of the Tide and Executive Director for Big Fish & Begonia.

Kling AI is one of the world’s leading AI creative platforms, focused on next-generation tools for visual storytelling, cinematic workflows and creative production innovation. Since its launch, It has empowered over 60 million creators worldwide.
Hashtag: #KlingAI

The issuer is solely responsible for the content of this announcement.

28857

Binzhou Unveils “15th Five-Year Plan” Blueprint: A Strategic Focus on Quality Enhancement and Sustainable Development

BINZHOU, CHINA – Media OutReach Newswire – 27 May 2026 – The Information Office of Binzhou Municipal People’s Government recently held a press conference to officially release the Outline of the 15th Five-Year Plan for National Economic and Social Development of Binzhou City (hereinafter referred to as “the plan”). The plan sets forth the overarching goals, primary tasks, and major initiatives guiding the city’s economic and social trajectory from 2026 to 2030, charting a comprehensive blueprint for the coming five years.

The scenery of Binzhou City
The scenery of Binzhou City

During the conference, city officials reviewed the achievements of the “14th Five-Year Plan” period, noting that the progress made over the past five years has laid a solid foundation for the upcoming phase. The formulation of the new plan adhered to an open and inclusive approach, extensively incorporating feedback from various sectors of society. Following 36 rounds of revisions, the finalized document comprises 16 chapters and 77 sections, supported by 528 key projects designated for implementation.

The plan highlights five distinct features and centers on the comprehensive elevation of the city’s “Eight Qualities,” covering industrial development, innovation capacity, openness, ecological environment, cultural and humanistic development, public services, governance systems, and quality of life. Relevant officials further elaborated on key priorities, including the development of a modern industrial system, science and technology innovation-driven growth, advancement of new industrialization, implementation of the rural revitalization strategy, and optimization of public welfare and well-being.

Binzhou officials emphasized that the plan is not merely a policy document, but a strategic choice and action commitment for the city’s development toward 2030. Over the next five years, Binzhou is poised to fulfill its mission of “taking the lead and shouldering greater responsibilities.” Guided by the plan, the city will continue to exert effort in enhancing urban quality, driving innovation-led transformation, and improving public well-being, thereby writing a distinctive chapter of development within China’s broader journey toward modernization.

Hashtag: #BinzhouInformationOffice

The issuer is solely responsible for the content of this announcement.

28857

CGTN: China and Serbia Call for Strengthened Artistic Exchanges and Deeper Friendship

BEIJING, CHINA – Media OutReach Newswire – 27 May 2026 – CGTN published an article highlighting cultural and artistic exchange as a booster in strengthening China-Serbia friendship. It underscores the effort by Peng Liyuan, wife of Chinese President Xi Jinping, in fostering artistic and cultural exchanges, while offering a broader view of the cultural and artistic activities in the two countries that serve to foster mutual understanding between the people of the two countries.

photo.png

Peng Liyuan, wife of Chinese President Xi Jinping, and Tamara Vucic, wife of Serbian President Aleksandar Vucic, visited Beijing Dance Academy on Monday.

In the dance studios, they observed with keen interest the teaching of Chinese dance, ballet and other dances. They then watched the students’ performances and had cordial exchanges with teachers and students in a lively and warm atmosphere.

Watching ballet practice and Chinese dance rehearsals, Peng said that dance art transcends national borders, conveys cultures and ideas, and plays a unique role in people-to-people exchanges and mutual learning.

Peng expressed hope that artists from both countries would strengthen exchanges and cooperation to create more outstanding works. Tamara Vucic also voiced her willingness to promote cultural and artistic exchanges between the two countries and contribute to the deepening of Serbia-China friendship.

Art as a bridge of China-Serbia friendship

The exchange of arts has consistently played an important role throughout the history of China and Serbia’s friendship.

At the invitation of Tamara Vucic, Peng visited the National Museum of Serbia in 2024, the largest and oldest museum in the country. Peng and Tamara Vucic toured the museum’s painting exhibition together, watched demonstrations of traditional Serbian women’s hand weaving, and even tried making felt balls – souvenirs made of felt wool – which preserve the traditional and cultural heritage of Serbia.

During the visit, Peng repeatedly expressed appreciation for Serbian art and crafts, praising the exquisite and distinctive craftsmanship while noting the cultural heritage they carry. She expressed hope that cultural exchanges and cooperation between China and Serbia would be enhanced, in order to build bridges for dialogue among civilizations.

Cultural and artistic exchanges have long been an integral part of relations between the two countries.

In 1955, Kolo, Serbia’s national ensemble, made its first visit to China, marking the beginning of a long-lasting friendship that has persisted to the present day.

In a photo exhibition that marks the 70th anniversary of the first China tour by Kolo in 2025, former Secretary of State for the Ministry of Culture of Serbia Lav Pajkic said cultural cooperation is an important component of Serbia-China relations.

Over the past 70 years, the civilizations of Serbia and China have appreciated one another and engaged in exchanges and mutual learning, once again reaffirming the ironclad friendship between the two countries, he added.

Cultural exchange boosts a shared future and common prosperity

Cultural exchanges in recent years have bloomed as China and Serbia’s strategic partnership continues to reach new heights.

In Chinese President Xi Jinping’s talks with Serbian President Aleksandar Vucic, Xi emphasized that China and Serbia need to fully expand cooperation in culture, education, sports and tourism and at the subnational level, so as to carry forward the traditional friendship between the Chinese and Serbian peoples.

In 2024, Beijing People’s Art Theatre traveled to Belgrade to perform Our Jing Ke, a drama performance written by Nobel Prize Laureate Mo Yan, to show the Serbian people the artistic style and aesthetic expressions of Chinese performance arts. In January 2026, an exhibition showcasing China’s renowned Dehua porcelain opened in Belgrade, providing a window into traditional Chinese craftsmanship. In April, the Confucius Classroom at the Philological High School celebrated International Chinese Language Day by singing popular Chinese songs, practicing tai chi, and reciting their favorite passages of The Analects of Confucius.

These activities and art exhibitions have become important platforms and channels for China and Serbia to learn about each other.

According to a joint statement released after Xi and Vucic’s talks, the two countries will strive to open a new chapter in people-to-people exchanges and cultural integration. As a Serbian proverb goes, “Prijatelj je plod vremena” (friends are the fruits of time).

https://news.cgtn.com/news/2026-05-26/China-Serbia-call-for-stronger-artistic-exchanges-deeper-friendship-1NsuaNKYTbq/p.html


Hashtag: #CGTN

The issuer is solely responsible for the content of this announcement.

28857

醫克生物科學家團隊進駐國創中心國際總部的 愛滋病治療性疫苗臨床研究關鍵技術創新中心

朝向ICVAX®的成功再邁出重要的一步

香港 – Media OutReach Newswire – 2026年5月27日 – 總部位於香港科學園的醫克生物集團(「醫克生物」)欣然宣佈,粵港澳大灣區國家技術創新中心國際總部(「國際總部」)的愛滋病治療性疫苗臨床研究關鍵技術創新中心(「創新中心」)正式落成並啟用揭牌,中心的目標是關於醫克生物的愛滋病治療性疫苗(「ICVAX®」)臨床研究及商業化關鍵技術的研發及應用,ICVAX®的目標是在無需服用抗逆轉錄病毒療法(「ART」)的情況下達到功能性治癒愛滋病毒感染。 此項目獲得香港大學李嘉誠醫學院愛滋病研究所創始所長陳志偉教授及深圳市第三人民醫院盧洪洲院長擔任顧問合作開展。

【由左至右】:國際總部副主任曹騰飛博士,醫克生物企業融資總監兼聯合創始人劉高原先生,深圳清華大學研究院常務副院長、國際總部主任劉仁辰博士,醫克生物行政總裁兼聯合創始人金俠博士,醫克生物首席科學顧問兼聯合創始人陳志偉教授,醫克生物董事會主席兼聯合創始人鄭淇德醫生
【由左至右】:國際總部副主任曹騰飛博士,醫克生物企業融資總監兼聯合創始人劉高原先生,深圳清華大學研究院常務副院長、國際總部主任劉仁辰博士,醫克生物行政總裁兼聯合創始人金俠博士,醫克生物首席科學顧問兼聯合創始人陳志偉教授,醫克生物董事會主席兼聯合創始人鄭淇德醫生

國際總部坐落在河套深港科技創新合作區(「河套合作區」),是廣東省、深圳市和清華大學聯合部署的國家級綜合領域成果轉化平台,致力於打造具備全球視野、國際領先的重大技術創新及產業化平台。 其緊扣國家重大戰略需求,聚焦生物醫藥、高性能材料、人工智慧等關鍵賽道, 彙聚全球創新資源、聯動行業龍頭企業,開展有組織科研與成果轉化。

自1981年首次發現愛滋病以來,已有4,080萬人因愛滋病病毒感染而死亡。 目前,全球仍有超過4,410萬名愛滋病毒感染者。 雖然ART可以有效控制愛滋病毒,但仍然無法根治此病,並凸顯了免疫療法的重要性。 免疫療法旨在增強宿主的免疫反應,期望能在無需ART的情況下控制病毒複製,最終實現病毒的完全抑制,達到功能性治癒的效果。 醫克生物自主研發的創新型愛滋病治療性核酸藥物ICVAX®,能誘導具有廣譜、多功能的病毒特異性T細胞,以在無需服用ART的情況下實現功能性治癒愛滋病毒感染的目標。

醫克生物於2024年11月完成ICVAX® 藥物的首次人體一期臨床試驗。 結果顯示,該藥物具有卓越的安全性和良好的免疫原性。 將於2026年第二季度開展兩項多中心二期臨床試驗以評估ICVAX® 藥物在人體中的機理和療效,兩項皆是隨機、雙盲、安慰劑對照的臨床研究,而臨床試驗機構包括香港威爾斯親王醫院,以及國內八所三甲醫院進行,包括深圳市第三人民醫院、首都醫科大學附屬北京地壇醫院、首都醫科大學北京佑安醫院、廣州市第八人民醫院、天津市第二人民醫院、鄭州市第六人民醫院、成都市公共衛生臨床醫療中心和重慶市公共衛生醫療救治中心。

值得關注的是,在愛滋病藥物臨床試驗中,用於評估免疫學和病毒學指標的規範化檢測體系至關重要。 但國內缺乏針對臨床試驗中感染性樣本的標準操作規程,會阻礙ICVAX® 等新型傳染病療法的臨床開發與監管審批。 作為國際總部的重要一員,創新中心旨在建立符合國際標準的T細胞免疫原性與病毒儲存庫標準化臨床檢測體系,以及發掘與藥物效力相關的核心生物標誌物,填補國內在此領域的技術空白。 並希望通過配合醫克生物的ICVAX® 二期臨床試驗,為臨床試驗樣本檢測中制定標準化臨床精准檢測方法。

醫克生物集團行政總裁金俠博士表示:「我非常榮幸能被委任去領導此國際總部的技術創新中心重點項目。 同時,我亦非常感謝國際總部為此專案提供現代化、設備齊全的實驗室,以及資金資助支持初期兩年的研發開支。 我堅信,標準化檢測方法的制定不僅能夠提升我們ICVAX® 臨床試驗的品質,最終還將成為愛滋病及其他傳染病藥物臨床轉化領域的行業和國家標準。」

深圳清華大學研究院常務副院長、國際總部主任劉仁辰博士表示:「熱烈祝賀愛滋病治療性疫苗臨床研究關鍵技術創新中心正式揭牌成立。未來,國際總部會持續發揮平台資源優勢,落實全鏈條孵化服務。專案經理人將貫穿專案全週期開展服務保障,做好資源整合、人才引育、臨床對接、成果轉化等各項工作,為專案穩步推進保駕護航。」

隨著項目推進,ICVAX® 有望成為首個實現功能性治癒的愛滋病治療性核酸藥物,為全球 4,410 萬名感染者帶來新希望。 同時,專案所構建的標準化檢測平台與協同創新模式,將為其他重大傳染病創新藥物的研發提供可借鑒的範例,進一步強化大灣區生物醫藥產業的國際競爭力,助力國家生物安全與公共衛生體系建設。

Hashtag: #ImmunoCure #醫克生物


The issuer is solely responsible for the content of this announcement.

關於粵港澳大灣區國家技術創新中心國際總部

粵港澳大灣區國家技術創新中心(以下簡稱”大灣區國創中心”)是國家重點佈局建設的三個綜合類國家技術創新中心之一,擔負著實施科技創新驅動發展戰略、推動落實粵港澳大灣區發展規劃的重要使命。為開放集聚全球高端創新資源,推動科技成果轉化與產業化,由大灣區國創中心統籌,依託深圳清華大學研究院,在河套深港科技創新合作區深圳園區(以下簡稱”河套合作區”)建設粵港澳大灣區國家技術創新中心國際總部(以下簡稱”國際總部”)。

國際總部是大灣區國創中心的有機組成部分,致力於打造具備全球視野、國際領先的重大技術創新及產業化平台。國際總部定位於解決產業高品質發展面臨的重大挑戰,組織國際創新資源,聯合龍頭企業力量,開展有組織科研和有組織轉化,共同培育新質生產力。

欲瞭解更多關於粵港澳大灣區國家技術創新中心國際總部的資訊,請關注微信公眾號:粤港澳大湾区国创中心国际总部

關於醫克生物

醫克生物集團是一家處於臨床階段的生物科技集團,總部位於香港科學園。 醫克生物致力於自主創新的核酸藥物及抗體免疫療法的研發,針對傳染病、炎症、以及癌症。 醫克生物擁有兩項技術:「PD-1增強型核酸藥物平台」、以及「抗Δ42PD1抗體」。

欲瞭解更多關於醫克生物,請瀏覽:

28857

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

Another significant step towards the success of ICVAX®

HONG KONG SAR – Media OutReach Newswire – 27 May 2026 – Immuno Cure Group (“Immuno Cure“), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine (“ICVAX®) at the Center of International Innovation for Technology and Science (“CIITS”) located in Hetao, Shenzhen. The facility aims for the development and application of key technologies for the clinical research and commercialization of Immuno Cure’s ICVAX®. ICVAX® is developed by Immuno Cure with the aim of achieving antiretroviral therapy (“ART“)-free functional cure for HIV infection. This project is carried out in collaboration with Prof. Zhiwei CHEN, the Founding Director of the AIDS Institute of Li Ka Shing Faculty of Medicine, the University of Hong Kong (“HKU AIDS Institute“), and Prof. Hongzhou LU, President of the Third People’s Hospital of Shenzhen, in the capacity as advisors.

From left to right: Dr.Tengfei CAO, Deputy Director of CIITS; Mr. Tom LAU, Corporate Finance Director and Co-Founder of Immuno Cure; Dr. Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS; Dr. Xia JIN, CEO and Co-Founder of Immuno Cure; Prof. Zhiwei CHEN, Principal Scientific Advisor and Co-founder of Immuno Cure; Dr. Percy CHENG, Chairman and Co-Founder of Immuno Cure
From left to right: Dr.Tengfei CAO, Deputy Director of CIITS; Mr. Tom LAU, Corporate Finance Director and Co-Founder of Immuno Cure; Dr. Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS; Dr. Xia JIN, CEO and Co-Founder of Immuno Cure; Prof. Zhiwei CHEN, Principal Scientific Advisor and Co-founder of Immuno Cure; Dr. Percy CHENG, Chairman and Co-Founder of Immuno Cure

CIITS is a national-level achievement transformation platform co-built by Guangdong Province, Shenzhen Municipality, and Tsinghua University, and is located at the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone (“Hetao Co-operation Zone“). It is committed to building a world’s leading major technological innovation and industrialization platform with a global perspective. It focuses on key tracks including biomedicine, high-performance materials, and artificial intelligence (AI). It aims to aggregate global innovation resources, connect with leading enterprises, and conduct organized scientific research and achievement transformation to address national major strategic needs.

Since AIDS was first identified in 1981, 40.8 million people have died from HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it cannot cure the disease, highlighting the critical need for immunotherapies. Designed to enhance the host’s immune response, immunotherapies aim to achieve sustained viral control without lifelong ART, ultimately leading to complete viral suppression and functional cure. Immuno Cure’s proprietary innovative HIV therapeutic DNA vaccine, ICVAX®, induces broad-spectrum, polyfunctional virus-specific T cells to achieve the ultimate goal of ART-free functional cure of HIV infection.

Immuno Cure completed the first-in-human Phase I clinical trial of ICVAX® in November 2024, demonstrating excellent safety and promising immunogenicity. Two multi-center Phase II clinical trials—randomized, double-blind, and placebo-controlled—are scheduled to launch in Q2-2026 to evaluate the vaccine’s mechanism of action and efficacy. The trials will be conducted at Prince of Wales Hospital in Hong Kong, as well as eight top-tier hospitals in China, including the Shenzhen Third People’s Hospital, Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing Youan Hospital affiliated to Capital Medical University, the Eighth People’s Hospital of Guangzhou, the Second People’s Hospital of Tianjin, the Sixth People’s Hospital of Zhengzhou, Chengdu Public Health Clinical Medical Center, and Chongqing Public Health Medical Center.

Notably, standardized testing systems for evaluating immunological and virological indicators are crucial for HIV vaccine clinical trials. However, the lack of domestic standard operating procedures (SOPs) for infectious samples in clinical trials hinders the clinical development and regulatory approval of novel infectious disease therapies like ICVAX®. The mission of this research facility at CIITS is to establish an internationally aligned standardized clinical testing system for T-cell immunogenicity and viral reservoirs, as well as identify core biomarkers associated with vaccine efficacy — filling a domestic technical gap. Immuno Cure will offer the ICVAX® Phase II clinical trial to facilitate the development of this standardized precision testing method for clinical sample analysis.

Dr. Xia JIN, CEO of Immuno Cure, stated, “I am delighted to be appointed to lead this key project of CIITS. I would also like to thank CIITS for the fully fitted modern laboratory space and the RMB10.0m funding support for this 2-year initial phase. My whole scientific team is committed to contributing diligently to the success of this project. I have no doubt that the development of a standardised testing regime would not only enhance the quality of our clinical trials for ICVAX® but would also eventually be adopted as industry and national standards for the clinical translation of medicine for HIV/AIDS and other infectious diseases.

Renchen LIU, Executive Deputy Dean of Research Institute of Tsinghua University in Shenzhen and Director of CIITS, stated, “Warmest congratulations on the inauguration of the research facility for ICVAX® at the CIITS. In the future, CIITS will continue to leverage its platform resources to implement full-chain incubation services. Project managers will provide service support throughout the entire project period, ensuring the smooth progress of the project through resource integration, talent recruitment and development, clinical collaboration, and achievement transformation. These efforts will safeguard the steady progress of the project.”

As the project advances, Immuno Cure’s ICVAX® is positioned to become the world’s first therapeutic DNA vaccine to deliver an ART-free functional cure for HIV infection, bringing new hope to people currently living with HIV. In parallel, the standardized testing platform and collaborative innovation model developed through this effort will provide a scalable, replicable blueprint for R&D of novel therapies targeting other major infectious diseases. Together, these outcomes will strengthen the global competitiveness of biomedicine development in GBA and contribute to the development of national biosecurity capabilities and a more resilient public health system.

Hashtag: #ImmunoCure


The issuer is solely responsible for the content of this announcement.

About the Center of International Innovation for Technology and Science (“CIITS”)

Center of International Innovation for Technology and Science (CIITS), as the international headquarter of the Greater Bay Area National Center of Technology Innovation (GBA NCTI), is operated by Research Institute of Tsinghua University in Shenzhen (RITS). CIITS actively promotes the commercialization of technology and scientific advances with overseas and domestic innovation institutions and teams, as well as industry partners, focusing on areas such as biomedicine, advanced materials and artificial intelligence.

To learn more about CIITS, please follow the WeChat official account: gh_425f503135d5

About Immuno Cure

Immuno Cure is a clinical-stage biotechnology group headquartered at Hong Kong Science Park. Immuno Cure is committed to the R&D of innovative DNA vaccines and antibody immunotherapies for infectious diseases, inflammations, and cancers. Immuno Cure possesses two technologies: the “PD-1 Enhanced DNA Vaccine Platform” and the “Anti-Δ42PD1 Antibody”.

To learn more about Immuno Cure, please visit:

28857

Thailand Positions SITE 2026 as a Regional Platform Where Innovation Meets Investment

Under the theme “Global Innovation Impact: The Year of Investment,” NIA is bringing together startups, investors, corporates, and global partners to turn innovation into real business opportunity and measurable impact.

BANGKOK, THAILAND – Media OutReach Newswire – 27 May 2026 – The National Innovation Agency (Public Organization), or NIA, under the Ministry of Higher Education, Science, Research and Innovation (MHESI), has officially launched SITE 2026. Organized under the concept “Global Innovation Impact: The Year of Investment,” the event is elevated to serve as a tangible platform of opportunities, bridging Thai innovations with global capital, partners, and networks.

Thailand Positions SITE 2026 as a Regional Platform Where Innovation Meets Investment

The expo will take place from June 25 – 27, 2026, at Paragon Hall, expanding its footprint to cover Nex Hall on the 5th floor and the SCBx Next Stage on the 4th floor of Siam Paragon to accommodate the continuously growing activities and collaborative networks.

According to Dr. Krithpaka Boonfueng, Executive Director of NIA, the goal is to create a platform where opportunity meets capital, and innovation meets global partners. In her view, innovation impact is no longer defined by novelty alone, but by the value it creates and the measurable outcomes it can deliver.

That shift matters in the current regional context. For Thailand, the conversation is no longer only about building promising startups. It is about making innovation more investable, more connected, and more capable of generating real outcomes across business and society.

NIA has framed SITE 2026 around several strategic drivers, including future-focused technologies, investment-readiness innovation, global connectivity, multiplier effects across the economy, and stronger strategic alliances. Together, these are intended to help position Thailand more visibly within the regional and global innovation landscape.

The investment angle is especially significant. NIA’s latest figures indicate that startup investment in Thailand reached approximately USD 120 million in 2025, while capital ready to be deployed within Thailand’s innovation ecosystem exceeded USD 1 billion. Against that backdrop, SITE 2026 is being presented as a timely platform to connect investable innovation with available capital in a more deliberate and market-oriented way.

From a programme perspective, SITE 2026 is structured to appeal not only to startups, but also to investors, corporates, and innovation leaders looking for deal flow, market signals, and partnership opportunities. Key features include:

  • global forums and thought-leadership sessions,
  • showcases of 100 future-focused startups,
  • 100 market-ready innovations,
  • startup pitching opportunities,
  • Business Matching sessions,
  • an International Pavilion,
  • youth innovation platforms through Startup Thailand League,
  • and cross-disciplinary collaboration through SYNC Design & Innovation and Maker Faire Bangkok.

For investors and business decision-makers, the strongest draw may be the event’s ambition to function as a real investment marketplace. SITE 2026 is designed to bring Thai startups together with venture capital firms, corporate venture capital arms, international investors, and strategic business partners in one integrated venue. It also opens broader regional connectivity through participation and collaboration from countries including Japan, South Korea, China, Hong Kong, and Singapore.

That positioning was echoed during the event’s launch discussion, where speakers from government, innovation finance, venture capital, and the startup community shared a common view: innovation today must lead to measurable outcomes— not only in technology development, but in market access, business competitiveness, funding, and international growth.

For Thailand, that means strengthening its role not simply as a place where innovation happens, but as a market where innovation can be funded, scaled, and connected internationally.

For regional investors, corporates, and ecosystem leaders, SITE 2026 offers a closer look at how Thailand is attempting to move in that direction.

SITE 2026 will be held from 25–27 June 2026 at Paragon Hall, Siam Paragon, Bangkok. Admission is free of charge. More information and registration are available at site.nia.or.th.

Exploring Thailand’s Next Wave of Investable Innovation

SITE 2026 brings together startups, investors, corporates, and global partners on one platform to explore business opportunity, market-ready innovation, and cross-border collaboration.

SITE 2026 is positioning Thailand as a regional platform where innovation meets investment, bringing together startups, investors, corporates, and global partners in Bangkok this June.

Hashtag: #SITE2026

The issuer is solely responsible for the content of this announcement.

28857

The Naka Island, Phuket Unveils a Renewed Luxury Escape with Enhanced Private Pool Villas, Dining, Wellness, and MICHELIN One Key Recognition

Five-star resort and MICHELIN One Key destination emerges from a series of enhancements, featuring a stunning seafront pool, private pools in every villa, reimagined restaurants and bars, an expanded spa, and more — inviting guests to immerse in luxury, serenity, and a renewed island experience.

PHUKET, THAILAND – Media OutReach Newswire – 27 May 2026 – The Naka Island, a Luxury Collection Resort & Spa, Phuket, the five-star sanctuary nestled on a secluded island in the Andaman Sea, has unveiled a series of transformative enhancements that promise to elevate the guest experience. With a renewed focus on luxury, relaxation, and rejuvenation, these upgrades will allow guests to fully immerse in the island’s natural beauty while enjoying unparalleled comfort and world-class service.

Final Photo for press release

The signature Beachside Infinity Pool now unveiled after a transformational renovation. Set against the mesmerizing backdrop of the turquoise sea, this stunning pool has become the resort’s centerpiece —a true icon of luxury and leisure. Guests can bask in the mirror-like waters, which reflect the ever-changing rhythms of the day, from the golden hues of sunrise to the vibrant oranges and reds of sunset. The pool’s shape, inspired by Naka Yai Island and the resort’s logo, invites guests to both swim and soak in the tranquil beachside atmosphere. A chic new deck with cozy cabanas provides the perfect spot to relax in comfort and style.

For those seeking more privacy, the resort’s newly-upgraded Villas offer an elevated experience. Set amid lush gardens or perched on the shores of the Andaman, these private sanctuaries have been enhanced with contemporary interiors, bespoke furnishings, and thoughtful touches that capture the essence of the island. Whether enjoying a serene morning dip or a tranquil evening swim, every moment in these villas is designed to make a lasting impression. The fully air-conditioned, spa-inspired bathrooms have also been reimagined to exude even more indulgence and luxury.

For moments of pure tranquility, Spa Naka by HARNN has been enhanced and expanded with two additional treatment rooms (increasing from six to eight). Wellness seekers can step into a lush, natural oasis with replenished tropical gardens, pathways, and relaxation areas to create a more soothing ambiance, harmoniously connected with the environment and the rhythm of the ocean.

In addition, the resort’s Multi-Purpose Sala has been thoughtfully refreshed to provide enhanced comfort and versatility for guests and groups. Now featuring air-conditioning and a state-of-the-art LED screen, the venue offers an elevated indoor setting for meetings, private activities, workshops, and special occasions. This adaptable space creates a seamless backdrop for intimate gatherings, curated events, and meaningful celebrations, all within the tranquil serenity of the island.

The Naka Island, Phuket, is also set to delight guests with a reimagined culinary experience at its three refreshed restaurants and a chic sunset bar. At Aiyara, the resort’s signature dining destination, guests can savor authentic Thai cuisine. The restaurant’s revitalized design, inspired by the Thai elephant, evokes the spirit of the kingdom’s rich cultural heritage. Here, talented chefs curate dishes using the freshest ingredients from Phuket’s farms and fishing villages, telling a story of Thailand’s coastal traditions with every bite.

At Veranda, the all-day restaurant with sweeping ocean views, guests can indulge in a refined international menu. Influenced by the natural beauty of coral reefs, the design incorporates reclaimed driftwood, rattan, and pottery to celebrate the connection between sea and earth. Whether dining indoors or on the idyllic outdoor terrace, Veranda offers an elegant atmosphere for every occasion., Rum Chapel highlights the flavors of the Mediterranean with a focus on fresh, local seafood and premium imported ingredients like olive oil, burrata, and Italian wines, Rum Chapel’s culinary offerings are both cosmopolitan and comforting.

For the perfect end to the day, guests can unwind at Zbar, the newly reimagined social venue perched on the tip of the island. With its extended open-air terrace overlooking Phang Nga Bay, Zbar offers an exceptional space for relaxation and socializing. As the sun sets, the “Sunset Ceremony” invites guests to light a candle and make a wish, marking a special connection with the island’s coastal heritage. After dark, the venue transforms into an intimate setting for light, Japanese-inspired plates and cocktails.

As the only resort on Naka Yai Island, a glittering gem in the Andaman Sea, The Naka Island, Phuket offers an unparalleled blend of serenity and adventure. With 90 stylish rooms, suites, and pool villas, world-class wellness offerings, dining excellence, curated activities, and island-hopping excursions, this secluded oasis is the ultimate destination for all types of island vacations—from solo retreats and family getaways to romantic escapes, destination weddings, and dreamy honeymoons.

To learn more about The Naka Island, a Luxury Collection Resort & Spa, Phuket, please call +66 (0) 76 371 400, email naka.reservations@luxurycollection.com, or connect with us via these channels:

Website: www.marriott.com/en-us/hotels/pyxlc-the-naka-island-a-luxury-collection-resort-and-spa-phuket/overview
Facebook: www.facebook.com/thenakaisland
Instagram: www.instagram.com/nakaislandphuket
Line Official: lin.ee/6wOs1Rw

Hashtag: #TheLuxuryCollection #NakaIsland #Phuket

The issuer is solely responsible for the content of this announcement.

About The Luxury Collection® Hotels & Resorts

The Luxury Collection® is comprised of world-renowned hotels and resorts offering unique, authentic experiences that evoke lasting, treasured memories. For the global explorer, The Luxury Collection offers a gateway to the world’s most exciting and desirable destinations. Each hotel and resort are a unique and cherished expression of its location; a portal to the destination’s charms and treasures. Originated in 1906 under the CIGA® brand as a collection of Europe’s most celebrated and iconic properties, today The Luxury Collection brand is a glittering ensemble of over 130 of the world’s finest hotels and resorts in 42 countries and territories. All of these hotels, many of them centuries old, are internationally recognized as being among the world’s finest. For more information and new openings, visit or follow and . The Luxury Collection is proud to participate in Marriott Bonvoy®, the global travel program from Marriott International. The program offers members an extraordinary portfolio of global brands, exclusive experiences on and unparalleled benefits including free nights and Elite status recognition. To enroll for free or for more information about the program, visit .

About Marriott Bonvoy®

Marriott Bonvoy’s extraordinary portfolio offers renowned hospitality in the most memorable destinations in the world, with more than 30 brands that are tailored to every type of journey. From The Ritz-Carlton and St. Regis to W Hotels and more, Marriott Bonvoy has more luxury offerings than any other travel program. Members can earn points for stays at hotels and resorts, including all-inclusive resorts and premium home rentals, and through everyday purchases with co-branded credit cards. Members can redeem their points for experiences including future stays, Marriott Bonvoy Moments™, or through partners for luxurious products from Marriott Bonvoy Boutiques®. To enroll for free or for more information about Marriott Bonvoy, visit .

28857

靄華押業2026財年多賺近48% 淨息差續拓闊展現業務韌性

審慎風控顯著成效 財政持續穩健 派末期息每股1.15港仙

業績亮點:

  • 股東應佔溢利按年增長約47.8%至約82.6百萬港元
  • 純利率按年增長約16.2個百分點至約50.2%
  • 應收貸款減值虧損撥備按年大減約72.6%至約12.7百萬港元
  • 典當貸款業務收益按年增長約12.9%至約98.6百萬港元
  • 派末期股息每股1.15港仙

香港 – Media OutReach Newswire – 2026年5月27日 – 靄華押業信貸控股有限公司(股份代號:1319.HK,「本集團」或「靄華」)董事會公佈其全年業績及財務狀況。截至2026年2月28日止年度(「2026年財政年度」),集團錄得收益約164.4百萬港元。年內,股東應佔溢利錄約82.6百萬港元,較截至2025年2月28日止年度(「2025年財政年度」)上升約47.8%;另淨息差持續擴闊至17.2%。

於2026年財政年度,集團持有現金及現金等價物(經扣除銀行透支)錄約376.9百萬港元,較2025年財政年度大幅增加約74.8%;資產淨額則按年增至約1,155.7百萬港元。同時,集團借貸比率按年持續降至4.1%。年內,每股基本盈利按年增加約48.3%至4.3港仙。董事會建議派發末期股息每股1.15港仙。

業務回顧

按揭抵押貸款業務

於2026年財政年度,宏觀經濟已進入逐步復甦階段,融資需求隨之穩步回升。集團年內按揭抵押貸款業務錄得收益約65.8百萬港元,而應收按揭抵押貸款總額約為612.5百萬港元。年內,按揭抵押貸款業務的淨息差約為10.1%。

年內,集團於放款活動方面繼續保持嚴謹及審慎風險導向的策略。雖然住宅物業市場已出現令人鼓舞的回穩跡象,本集團鑑於工商物業供應持續過剩及估值壓力,對該等板塊維持高度警惕。我們的審批策略持續聚焦建構具韌性的貸款組合,優先選擇高質素抵押品及審慎的貸款對估值比率。於2026年財政年度,第一按揭之平均貸款對估值比率約為56.27%,而次級按揭之平均整體貸款對估值比率則約為40.82%,其中集團經手之次級按揭之平均貸款對估值比率約為3.73%。

應收貸款減值虧損撥備由2025年財政年度約46.3百萬港元,減至2026年財政年度約12.7百萬港元,按年減少約72.6%,反映集團穩健的信貸風險管理。

典當貸款業務

於2026年財政年度,典當貸款業務的收益增加約12.9%至約為98.6百萬港元。年內,盈利能力進一步得益於出售經收回資產之收益由2025年財政年度約11.1百萬港元,大幅增加約73.0%至約19.2百萬港元。上述表現主要受惠於金價屢創新高,以及二手奢侈品市場(尤其是高端鐘錶)交投活躍,進一步鞏固典當貸款業務作為對沖宏觀經濟波動的穩健、策略性工具的地位。

年內,集團繼續投放資源於廣告及宣傳,以提升品牌曝光度,成功帶動對貸款額超過100,000港元的一對一典當貸款預約服務的需求。

前景

展望未來,本集團對環球經濟復甦抱持審慎樂觀態度。儘管宏觀經濟及地緣政治不確定性或將持續存在,我們仍將堅守積極而審慎的經營策略,確保長遠持續增長,並為股東爭取最大回報。 在按揭抵押貸款市場方面,我們將採取經審慎校準的差異化策略。本集團認為住宅物業板塊前景較為樂觀,並擬把握利率環境趨穩的契機,積極物色優質按揭抵押貸款機遇。相反,我們對工商物業板塊則維持審慎及警惕的取態。鑑於存貨供應結構性過剩及不良資產比例上升等挑戰,本集團於信貸審批及抵押品評估方面將實施更嚴格的監控,以減緩估值風險。

就核心業務而言,我們預計在金價走勢堅穩及流動資金管理需求持續的支持下,典當貸款業務將繼續保持韌性。為進一步提升營運效率,本集團正積極優化當舖分行網絡,有策略地在既有服務區域內物色更具成本效益的選址,以將現有當舖分行遷往租賃條款更有競爭力的物業,藉此在維持市場領先地位之餘降低營運開支。

同時,我們與PACM集團的策略合作仍是推動地域多元化的重要動力。透過在嚴格投資監控下積極於已發展市場探索機構信貸的商機,本集團具備有利條件可在行業格局持續演變之際靈活應對,並為全體持份者創造穩定價值。

集團主席、行政總裁兼執行董事陳啟豪先生表示:「當前全球地緣政治與宏觀經濟不確定性交織,環球經濟復甦面臨一定壓力,亦為本地物業市場前景帶來持續挑戰。面對複雜的外圍環境,靄華始終堅守積極而審慎的經營策略,核心典當業務在此市況下,充分發揮了對沖宏觀經濟波動的策略性工具角色,令集團在考驗中展現出強大的發展韌性。展望未來,我們將採取經審慎校準的差異化策略,持續推動地域多元化策略,在嚴格的投資監控下,積極於已發展市場探索商機,多元化拓展收入來源及客戶群,努力為股東創造長遠而穩健的回報。」

Hashtag: #OiWah #靄華

The issuer is solely responsible for the content of this announcement.

關於靄華押業信貸控股有限公司

靄華為香港融資服務供應商,主要提供短期有抵押融資,包括典當貸款及按揭抵押貸款。集團首間典當店於1975年在香港成立,現時共有10間典當店和1間優質服務中心,遍佈香港多個地點,並於2009年將業務擴展至按揭抵押貸款服務。集團股份於2013年3月12日正式於香港交易所主板掛牌,是首間本地上市的當舖。

28857

Oi Wah FY2026 Net Profit Surges by Nearly 48%, Continuous Expansion of Net Interest Margin Demonstrates Business Resilience

Prudent Risk Management Yields Solid Outcomes metrics, Core Pawn Business Demonstrates Resilient Growth with Proposed Final Dividend of HK$1.15 cents per share

Results Highlights:

  • Profit for the year attributable to shareholders increased by approximately 47.8% YoY to approximately HK$82.6 million
  • Net profit margin increased by approximately 16.2 p.p. YoY to approximately 50.2%
  • Impairment losses recognized on loan receivables decreased by approximately 72.6% YoY to HK$12.7 million
  • Revenue from pawn loan business increased by approximately 12.9% YoY to approximately HK$98.6 million
  • Proposed final dividend of HK$1.15 cents per share

HONG KONG SAR – Media OutReach – 27 May 2026 – The board of directors of Oi Wah Pawnshop Credit Holdings Limited (HKEx stock code: 1319.HK, the “Group” or “Oi Wah”) announced its annual results and its financial position. For the year ended 28 February 2026 (“FY2026“), the Group recorded revenue of approximately HK$164.4 million. Profit attributable to shareholders of the Company reached approximately HK$82.6 million, representing an increase of 47.8% compared to the year ended 28 February 2025 (“FY2025“). During the year, net interest margin expanded to approximately 17.2%.

As of 28 February 2026, the cash and cash equivalents (net of bank overdraft) amounted to approximately HK$376.9 million, representing a substantial increase of approximately 74.8% YoY. The net assets increased to approximately HK$1,155.7 million. Concurrently, the gearing ratio dropped to 4.1%. During the year, the earnings per share increased by approximately 48.3% YoY to HK 4.3 cents. The Board of Directors recommends a final dividend of HK 1.15 cents per share.

BUSINESS REVIEW

Mortgage loan business

In FY2026, the economy entered a phase of gradual recovery, leading to a steady resurgence in financing demand. The revenue from the mortgage loan business was approximately HK$65.8 million and accounted for approximately 40.0% of the Group’s total revenue during the year. The gross mortgage loan receivables were approximately HK$612.5 million as at 28 February 2026. During the year, net interest margin of the mortgage loan business was approximately 10.1%.

In FY2026, the Group maintained a disciplined and risk-sensitive approach in its lending activities. While we observed an encouraging stabilization in the residential property market, the Group exercised intensified vigilance toward the commercial and industrial sectors due to persistent supply overhangs and valuation pressures. Our underwriting strategy remained focused on building a resilient loan portfolio by prioritizing high-quality collaterals and prudent loan-to-value ratios. During the year, the average loan-to-value ratio for first mortgage was approximately 56.27%, while overall average loan-to-value ratio for subordinate mortgage was approximately 40.82% of which, average loan-to-value ratio of subordinate mortgage that the Group participated in was approximately 3.73%.

Reflecting our robust credit risk management, the charge for impairment losses recognized on loan receivables decreased from approximately HK$46.3 million to approximately HK$12.7 million, representing a decrease of approximately 72.6% or HK$33.6 million.

Pawn Loan Business

The revenue from the pawn loan business increased by approximately 12.9% to approximately HK$98.6 million in FY2026. The business’s profitability was further bolstered by a significant 73.0% increase in the gain on disposal of repossessed assets, which reached approximately HK$19.2 million as compared to approximately HK$11.1 million in FY2025. This performance was mainly attributed to the unprecedented strength of gold prices and a highly active secondary market for luxuries, particularly high-end timepieces. These factors have further solidified the pawn loan business as a resilient and strategic hedge against broader economic volatility.

During the year, the Group continued to channel resources to advertising and promotion to enhance the Group’s brand exposure. Such effort has generated demand for one-to-one pawn loan appointment services for pawn loans exceeding HK$0.1 million.

PROSPECTS

Looking ahead, the Group maintains a stance of cautious optimism regarding the global economic recovery. While macroeconomic and geopolitical uncertainties may persist, we remain dedicated to a proactive yet prudent strategy to ensure sustainable long-term growth and maximize returns for our shareholders.

Within the mortgage loan market, our strategy will be characterized by a calibrated and divergent approach. We continue to hold an optimistic outlook on the residential property segment, where we intend to capitalize on the stabilizing interest rate environment by identifying high-quality mortgage opportunities. Conversely, we maintain cautious and vigilant towards the commercial and industrial sectors. Given the structural challenges of inventory overhang and the increasing prevalence of distressed assets, the Group will exercise intensified oversight in its credit underwriting and collateral appraisal to mitigate valuation risks.

Regarding our core operations, we anticipate our pawn loan business to remain resilient, supported by a firm gold price trajectory and sustained demand for liquidity management. To further enhance operational efficiency, the Group is actively optimizing its pawn shop network. We are strategically identifying more cost-effective locations within our established service areas, aiming to relocate our pawn outlets to premises with more competitive lease terms to reduce operating overheads while maintaining our leading market presence.

Simultaneously, our strategic partnership with PACM Group remains a key driver for geographic diversification. By proactively exploring institutional credit opportunities in developed markets while maintaining rigorous investment oversight, the Group is well-positioned to navigate evolving industry dynamics and deliver stable value to all stakeholders.

Mr. Edward Chan, Chairman and CEO of the Company, said, “Global geopolitical and macroeconomic uncertainties intertwine, placing pressure on the global economic recovery and posing ongoing challenges to the local property market. In the face of a complex external environment, Oi Wah has consistently adhered to a proactive yet prudent management strategy. Our core pawn loan business has fully demonstrated its role as a strategic tool to hedge against macroeconomic fluctuations, showcasing the Group’s strong resilience amidst market challenges.

Looking forward, we will adopt a carefully calibrated differentiation strategy and continue to drive regional diversification. Under strict investment monitoring, we will actively explore business opportunities in developed markets to further expand our revenue streams and customer base, striving to deliver long-term, stable, and sustainable returns for our shareholders.”

Hashtag: #OiWah

The issuer is solely responsible for the content of this announcement.

About Oi Wah Pawnshop Credit Holdings Limited

Oi Wah is a financing service provider in Hong Kong, mainly providing short-term secured financing, including pawn loans and mortgage loans. The Group established its first pawnshop in 1975 and currently owns 10 pawnshops and one premium service center in various locations in Hong Kong. Oi Wah diversified into mortgage loan business in 2009. The Group is the first local pawn shop which successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited on 12 March 2013.

28857

Kweichow Zhenjiu Showcases a Formidable Presence at 2026 Vinexpo Asia in Hong Kong

The First Hong Kong-Listed Baijiu Company Interprets Eastern Distilling Philosophy through a Contemporary Lens

HONG KONG SAR – Media OutReach Newswire – 27 May 2026 – ZJLD Group Inc. (“ZJLD” or the “Company”, together with the Company’s subsidiaries, collectively the “Group”) (SEHK stock code: 06979. HK), a leading pioneer in China’s baijiu industry and the first baijiu company listed on the Hong Kong Stock Exchange, is pleased to announce that its flagship sauce-aroma baijiu brand, Kweichow Zhenjiu, has staged a high-profile showcase at Vinexpo Asia 2026.

Leveraging Hong Kong’s preeminent position as a global trade hub and a dynamic multicultural crucible, the exhibition convenes top-tier spirits exhibitors and industry authorities from more than 20 countries and regions worldwide. Amid a landscape in which global spirits brands actively pursue cross-cultural breakthroughs, this edition of Vinexpo Asia prominently featured a “Be Spirits Hong Kong” pavilion. Serving as a premier “super-connector”, the platform has established sophisticated dialogue mechanisms and collaborative bridges, seamlessly accelerating the integration of Chinese baijiu into the international spirits market. Kweichow Zhenjiu’s participation marks a profound advancement in the Group’s internationalization strategy, serving as an invaluable window into the cultural essence of Chinese baijiu for global investors and high-end consumer segments.

Full-Spectrum Portfolio on Display: The Seamless Convergence of Craftsmanship Heritage and Modern Expression

Kweichow Zhenjiu curated a comprehensive product lineup tailored to diverse consumption dimensions, including mass consumption, business banquets, high-end collections, and contemporary lifestyle appreciation. Among the highlights, the strategic new offering “News Craft Beer” is masterfully tailored for the next generation of consumers and global audiences. Characterized by its crisp and modern-tasting profile, it pioneeringly explores diversified consumption scenarios, vividly embodying the innovative DNA of this time-honored brand.

As the brand’s pinnacle collector-level masterpiece, the Grand “Da Zhen 2020” impressively features the legendary calligraphy of the Chinese character “Zhen”(珍), penned by Shen Zhou, one of the iconic “Four Great Masters of the Ming Dynasty”. Seamlessly blending classical aesthetic philosophy with modern industrial design, the bottle incorporates intricate 3D hot foil embossing, encased in intangible cultural heritage Xuan paper (宣紙), and a bespoke, handcrafted outer box. The baijiu itself is meticulously master-blended by five national-level baijiu judges, harmonizing years of premium base liquor with exceptionally rare vintage-aged reserves, epitomizing the ultimate value in high-end connoisseurship and collection.

In addition, the brand simultaneously presented its flagship classic expressions, including “Lao Zhenjiu(Classic Zhenjiu), “Zhen 15“, and “Zhen 30“. Also capturing widespread attention was its high-end vantage package-free[PN1] series, featuring “Zhen 2014“, “Zhen 2013“, “Zhen 30” and “Zhen 15“. Embracing a minimalist aesthetic, this sophisticated range transparently conveys the liquor’s intrinsic quality and authentic vintage value, proactively aligning with the evaluation paradigms of the international spirits industry.

Nurtured in the heartland of the core sauce-aroma baijiu production zone in Zunyi, Guizhou, Kweichow Zhenjiu unyieldingly adheres to time-honored solid-state fermentation techniques. Renowned for its elegant, full-bodied complexity, silky texture, and the legendary lingering fragrance that remains in the cup—the definitive “Zhen Style”—the Brand capitalizes on Hong Kong’s status as an international hub to transcend geographical and cultural boundaries, projecting the premium quality of Chinese sauce-aroma baijiu into the global arena.

Strategic Vision from Senior Leadership: Architecting a New Paradigm for Cross-Cultural Dialogue

Mr. Paul Ng, Vice President of International Affairs at ZJLD Group Inc., remarked: “Vinexpo Asia, as a world-class trade and exchange platform, serves as a vital conduit connecting Chinese baijiu with the global marketplace. Blessed with unparalleled strengths as an international financial and commercial hub, Hong Kong has always been a pivotal anchor for ZJLD’s strategic global expansion. In my vision, the global journey of Chinese baijiu extends far beyond regional market penetration; it represents the worldwide resonance of traditional Chinese baijiu craftsmanship, oriental etiquette, and lifestyle aesthetics.

Rooted in the core terroir of sauce-aroma baijiu production, ZJLD consistently prioritizes quality as our foundation and culture. Our successive high-profile appearances at prestigious international events, including Singapore’s TFWA Asia Pacific Exhibition & Conference, Vinexpo Hong Kong, and the International Wine & Spirits Fair, etc., not only demonstrate the solid execution of the Group’s global layout but also reflect our corporate responsibility as an industry leader to promote Chinese baijiu culture worldwide.

On this occasion, we adopt a more internationalized, concise and contemporary narrative to interpret the vintage value and artisanal aesthetics of Chinese sauce-aroma baijiu to global buyers and institutional investors. Looking ahead, ZJLD will steadfastly anchor our operations in Hong Kong, expand across the Asia-Pacific, and extend our reach to establish a truly global presence. We will actively engage with the global consumption ecosystem, tell compelling stories of Chinese baijiu, and pave the way for sauce-aroma baijiu to grace a broader international stage, commanding genuine prestige, appreciation, and cultural respect in mainstream global markets.”Hashtag: #ZJLD

The issuer is solely responsible for the content of this announcement.

About ZJLD Group Inc. (6979.HK)

Zhen Jiu was established in 1975 in Zunyi, Kweichow, China’s primary production area of sauce-aroma baijiu. In 1988, it was honored with the National Quality Award at the 5th National Wine Appreciation Conference. In the same year, the Protocol Department of the Ministry of Foreign Affairs, the Communication Department of the Ministry of Economy and Trade, and the Great Hall of the People Management Bureau announced that it would become one of the two sauce-aroma baijius served at state banquets. It is also known as one of the “Three Representative Baijiu Brands in Kweichow”.

ZJLD Group Inc. is a leading baijiu group in China that is devoted to offering premium baijiu products, including sauce-aroma, mixed-aroma, and strong-aroma. According to Frost & Sullivan statistics, the flagship brand Zhenjiu has maintained its position for two consecutive years (2024 and 2025) as the fourth-largest sauce-aroma baijiu brand in China and the third largest in Guizhou Province, based on revenue. The Company operates four baijiu brands in China, including two national baijiu brands, Zhen Jiu and Li Du, and two regional brands, Xiangjiao and Kaikouxiao. ZJLD prides itself on inheriting the time-honored baijiu-brewing techniques and reinvigorating them to develop iconic products. It strives to create a wide variety of aromatic and mellow baijiu products to meet diverse consumer preferences, seize broader market opportunities, and promote traditional Chinese baijiu culture.

28857